Stay in the know with VTCRC news & happenings. Sign up for our email list.

Mar 04, 2021

Tenant spotlight: KemPharm Pops 93% Pre-Market On FDA Approval Of ADHD Therapy

Feb 05, 2021

Tenant Spotlight: Landos Biopharma Announce Positive Results from a Phase 1 Study of NX-13 | VT Corporate Research Center

Feb 05, 2021

Tenant spotlight: Landos Biopharma Announces Pricing of Initial Public Offering

Jan 28, 2021

Tenant Spotlight: KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program